The CF33, Vaxinia and Oncarlytics Deal, page-229

I worry about CF33 being too effective and too cheap though.

I'm very supportive of the tech but IMU is also a threat to enormously wealthy medical groups that make immense amounts of money each year from cancer treatment (successful or not). Add in the cancer docytors, clinics, chemo suppliers, medical imaging groups etc and anyone with a effective cheap and easily administered broad brush cancer treatment will be risking the whole industry and its very very well remunerated participants.

I don't know the answer though, it surely can't be the status quo.

Good luck LC and co, curing cancer might be the easy bit.